liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Gender difference in adiponectin associated with cardiovascular mortality
Linköping University, Department of Medical and Health Sciences, Division of Cardiovascular Medicine. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Heart and Medicine Center, Department of Cardiology in Linköping.
Linköping University, Department of Medical and Health Sciences, Division of Drug Research. Linköping University, Faculty of Medicine and Health Sciences.
Linköping University, Department of Medical and Health Sciences, Division of Cardiovascular Medicine. Linköping University, Faculty of Medicine and Health Sciences.
Linköping University, Department of Medical and Health Sciences, Division of Cardiovascular Medicine. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Heart and Medicine Center, Department of Thoracic and Vascular Surgery.ORCID iD: 0000-0002-9095-403X
Show others and affiliations
2015 (English)In: BMC Medical Genetics, ISSN 1471-2350, E-ISSN 1471-2350, Vol. 16, no 9Article in journal (Refereed) Published
Abstract [en]

Background: It is important to identify cardiovascular diseases in patients at high risk. To include genetics into routine cardiological patients has therefore been discussed recently. We wanted to evaluate the association between high-molecular weight adiponectin and cardiovascular risk, and secondly in the same population evaluate if specific genotype differences regarding risk could be observed, and thirdly if gender differences could be seen. Method: Four hundred seventy-six elderly participants recruited from a rural community were included. All participants underwent a clinical examination, echocardiography, and blood sampling and the single nucleotide polymorphism (SNP) (rs266729) of adiponectin was analysed. Follow-up time was 6.7 years. Results: Those with high serum concentration of adiponectin had a more 2 fold increased cardiovascular risk, and it might be that females exhibits even higher risk where a more than 5 fold increased risk could be seen. The result could be demonstrated even in a multivariate model adjusting for well-known clinical risk factors. However, as the sample size was small the gender differences should be interpreted with caution. In the genotype evaluation the C/C carriers of the female group had a more than 9-fold increased risk of cardiovascular mortality, however the confidence interval was wide. Such genotype difference could not be found in the male group. Conclusion: High level of adiponectin was associated with increased cardiovascular risk. Also a gender difference in the genotype evaluation could be seen where the C/C carriers obtained higher risk in the female group but not in the male group. Thus, in order to identify patients at risk early, genetic analyses may add to the armamentarium used in the clinical routine. However, information should be regarded as hypothesis generating as the sample size was small and should stimulate further research in individualized cardiovascular prevention and treatment.

Place, publisher, year, edition, pages
BioMed Central / Springer Verlag (Germany) , 2015. Vol. 16, no 9
Keyword [en]
Genotypes; Gender; Prognosis
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:liu:diva-120043DOI: 10.1186/s12881-015-0187-9ISI: 000356038000001PubMedID: 26068642OAI: oai:DiVA.org:liu-120043DiVA: diva2:840013
Note

Funding Agencies|County Council of Ostergotland; University of Linkoping, Linkoping, Sweden; Swedish Heart and Lung Foundation

Available from: 2015-07-06 Created: 2015-07-06 Last updated: 2017-12-04

Open Access in DiVA

fulltext(539 kB)166 downloads
File information
File name FULLTEXT01.pdfFile size 539 kBChecksum SHA-512
e24f6ee52498b34e4bbb5a82ee4800064131891950866c255273c13add4296c765cb044a2fb2175bedf6c301d0bf4fbdbc00680b820984f107bda5f24fca4a0c
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Alehagen, UrbanVorkapic, EminaLjungberg, LizaLänne, TosteWågsäter, Dick

Search in DiVA

By author/editor
Alehagen, UrbanVorkapic, EminaLjungberg, LizaLänne, TosteWågsäter, Dick
By organisation
Division of Cardiovascular MedicineFaculty of Medicine and Health SciencesDepartment of Cardiology in LinköpingDivision of Drug ResearchDepartment of Thoracic and Vascular Surgery
In the same journal
BMC Medical Genetics
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 166 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 412 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf